Literature DB >> 14755372

Th1/Th2 cytokine profiles and their relationship to clinical features in patients following nonmyeloablative allogeneic stem cell transplantation.

Hongfeng Guo1, Zhenhua Qiao, Lei Zhu, Hongwei Wang, Liping Su, Yujin Lu, Yuee Cui, Bo Jiang, Qioujuan Zhu, Lianrong Xu.   

Abstract

An imbalance in helper T-cell type 1 (Th1) and type 2 (Th2) cytokines is suggested to play an important role in the pathogenesis of acute graft-versus-host disease (aGVHD). The aim of this study was to investigate the cytokine bias acquired by T cells after transplantation and its possible influence on relapse of original malignancy. Cytokine levels by peripheral CD4 and CD8 T cells were tested at various pre- and post-transplant time points with fluorescein isothiocyanate-based intracellular cytokine assay after short-term in vitro mitogenic stimulation (phorbol myristate acetate + ionomycin). In both CD4+ and CD8+ cells, interferon (IFN)-gamma-producing cell populations increased, indicating a shift to a Th1 cytokine profile with aGVHD. IFN-gamma-producing T cells was significantly lower in patients who experienced relapse of original disease compared to those who showed no signs of relapse and compared to normal controls. Our studies demonstrate that aGVHD correlates with a Th1 bias and that Th1 response may potentiate an effective immune surveillance. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14755372     DOI: 10.1002/ajh.10443

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  Prevention of acute graft-vs.-host disease by targeting glycolysis and mTOR pathways in activated T cells.

Authors:  Rui-Qing Zhou; Xiaobo Wang; Yong-Bin Ye; Bo Lu; Jing Wang; Zi-Wen Guo; Wen-Jian Mo; Zheng Yang; Pathomthat Srisuk; Le-Ping Yan; Xiao-Jun Xu
Journal:  Exp Ther Med       Date:  2022-05-16       Impact factor: 2.751

2.  Expression of CD200 on AML blasts directly suppresses memory T-cell function.

Authors:  S J Coles; R K Hills; E C Y Wang; A K Burnett; S Man; R L Darley; A Tonks
Journal:  Leukemia       Date:  2012-03-20       Impact factor: 11.528

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.